journal-newsletter.png
18.09.2026
 

Perfectly dosed: How medicine is tailor-made

 

Get well soon

When you get to a certain age, conversations sooner or later inevitably turn to physical ailments. These are often little things, not actual diseases. Still, there is a seemingly inexhaustible arsenal of horrors. I’m putting it rather flippantly here. Obviously, many people experience things that are anything but funny. When you are personally affected, healthcare can often seem inadequate and medical progress painfully slow. At the same time, the coronavirus pandemic showed what science and research are capable of. Vaccines were developed in what felt like record time. So shouldn’t today’s technologies be able to defeat chronic and rare diseases, or even cancer, just as quickly? With the vast amounts of data now being collected and artificial intelligence?

Expectations are high. Two things are especially high on everyone’s wish list: detecting diseases before they cause problems, and treatments that are tailored to each individual. The good news is that breakthroughs, both large and small, are becoming more frequent, and survival rates for many types of cancer have improved significantly in recent years. The question, then, is not whether the medicine of the future will look different, but how quickly these developments will find their way into our everyday lives. An example: The German weekly DIE ZEIT reported that a medication for postpartum depression has been available in Germany since July. This is all the more encouraging given that the condition has only been the subject of intensive research for a few decades.

“Medicine of the future” is not only the theme of the 2026 Year of Science, but also of this autumn issue of the Journal. Start-ups, high-tech companies and scientific institutes at Adlershof, Berlin’s science and technology hub, are working on early detection, precision medicine, optimal care for people with chronic conditions, digital assistance systems, and AI-supported diagnostics, in the most impressive ways. So I won’t keep you any longer: Why not start reading this encouraging issue straight away?

Sincerely,

Peggy Mory
Editor-in-chief

 

Further links

 
 

Website: latest issue, contact, subscription, archive

PDF: download the print version in German

 
 

Technology Park Berlin Adlershof in Social Media

Facebook Instagram LinkedIn Youtube

If you are no longer interested in receiving our newsletter, you can unsubscribe unsubscribeLink from the mailing list.

Legal Notice

WISTA Management GmbH | Rudower Chaussee 17 | 12489 Berlin
Phone +49 30 6392-2247 | pr@wista.de
Chief Executive Officer: Roland Sillmann | Amtsgericht Berlin-Charlottenburg
Commercial register: HRB 40362 | Tax identification number: DE 137202280

 

www.adlershof.de/en/journal
www.wista.de/en/legal-notice